Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

被引：0
|
作者：
Davis, J. C. [1 ]
van der Heijde, D. [2 ]
Braun, D. [3 ]
Dougados, M.
Clegg, D. O. [4 ]
Kivits, A. [5 ]
Fleischmann, R. [6 ]
Inmann, R. [7 ]
Ni, L. [8 ]
Lin, S. [8 ]
Tsuji, W. [8 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Hosp Cochin, Paris, France
[4] Univ Utah, Ctr Med, Salt Lake City, UT USA
[5] Altoona Ctr Clin Res, Duncansville, TX USA
[6] Univ Texas SW Med Ctr Dallas, Dallas, TX USA
[7] Toronto Western Hosp, Toronto, ON, Canada
[8] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：393 / 394
页数：2
相关论文
共 50 条
  • [21] Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up
    Kneepkens, E. L.
    Krieckaert, C. L. M.
    van der Kleij, D.
    Nurmohamed, M. T.
    van der Horst-Bruinsma, I. E.
    Rispens, T.
    Wolbink, G. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (10) : 1825 - 1829
  • [22] Lower Etanercept Levels Are Associated With High Disease Activity In Ankylosing Spondylitis Patients At 24 Weeks Of Follow-Up
    Kneepkens, Eva L.
    Krieckaert, Charlotte L. M.
    van der Kleij, Desiree
    Nurmohamed, Michael T.
    van der Horst-Bruinsma, Irene E.
    Rispens, Theo
    Wolbink, Gertjan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S646 - S647
  • [23] One-year efficacy of etanercept in ankylosing spondylitis
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, JJ
    Clegg, DO
    Kivitz, AJ
    Inman, RD
    Solinger, A
    Whitmore, J
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 390 - 390
  • [24] Clinical Efficacy and Safety of Etanercept Versus Sulfasalazine in Patients With Ankylosing Spondylitis A Randomized, Double-Blind Trial
    Braun, Juergen
    van der Horst-Bruinsma, Irene E.
    Huang, Feng
    Burgos-Vargas, Ruben
    Vlahos, Bonnie
    Koenig, Andrew S.
    Freundlich, Bruce
    ARTHRITIS AND RHEUMATISM, 2011, 63 (06): : 1543 - 1551
  • [25] Long term efficacy and safety of patients with ankylosing spondylitis treated with etanercept for years - Analysis of different types of response
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Song, I. H.
    Haibel, H.
    Heldmann, F.
    Brandt, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 745 - 746
  • [26] Effect of etanercept on iritis in patients with ankylosing spondylitis
    Rosenbaum, JT
    ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3736 - 3737
  • [27] Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis
    Dijkmans, Ben
    Emery, Paul
    Hakala, Markku
    Leirisalo-Repo, Marjatta
    Martin Mola, Emilio
    Paolozzi, Laurence
    Salvarani, Carlo
    Sanmarti, Raimon
    Sibilia, Jean
    Sieper, Joachim
    Van den Bosch, Filip
    van der Heijde, Desiree
    van der Linden, Sjef
    Wajdula, Joseph
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1256 - 1264
  • [28] Clinical efficacy of prospidin therapy in patients with ankylosing spondylitis
    Sukhikh, YN
    Nemtsov, BF
    Simonova, OV
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 389 - 389
  • [29] Efficacy and safety of adalimumab in ankylosing spondylitis
    Mounach, Aziza
    El Maghraoui, Abdellah
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2014, 6 : 83 - 90
  • [30] A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
    Anna Rita Giardina
    Angelo Ferrante
    Francesco Ciccia
    Rosalia Impastato
    Maria Concetta Miceli
    Alfonso Principato
    Giovanni Triolo
    Rheumatology International, 2010, 30 : 1437 - 1440
12345